Ticker

Analyst Price Targets — HTFL

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
August 14, 2026 12:41 pmMorgan Stanley$40.00$41.29TheFly Heartflow price target raised to $40 from $35 at Morgan Stanley
August 14, 2026 12:38 pmWilliam PlovanicCanaccord Genuity$45.00$40.19TheFly Heartflow price target raised to $45 from $37 at Canaccord
August 14, 2026 12:16 pmMatt O'BrienPiper Sandler$45.00$40.02TheFly Heartflow price target raised to $45 from $38 at Piper Sandler
August 14, 2026 11:02 amRick WiseStifel Nicolaus$45.00$31.01TheFly Heartflow price target raised to $45 from $40 at Stifel
August 14, 2026 10:56 amRobert W. Baird$45.00$31.01TheFly Heartflow price target raised to $45 from $34 at Baird
July 31, 2026 8:29 amDavid RescottRobert W. Baird$34.00$25.83TheFly Heartflow initiated with an Outperform at Baird
July 15, 2026 11:21 amRick WiseStifel Nicolaus$40.00$25.49StreetInsider HeartFlow (HTFL) Reiterated at Buy by Stifel After SCCT 2026 Meeting
May 15, 2026 10:56 amLarry BiegelsenWells Fargo$37.00$32.24TheFly Heartflow price target raised to $37 from $35 at Wells Fargo
May 15, 2026 10:49 amCanaccord Genuity$37.00$32.24TheFly Heartflow price target lowered to $37 from $43 at Canaccord
January 28, 2026 10:16 amWells Fargo$38.00$31.21TheFly Heartflow initiated with an Overweight at Wells Fargo

Latest News for HTFL

BlackRock Inc. Makes New $152.50 Million Investment in Heartflow, Inc. $HTFL

BlackRock Inc. acquired a new stake in Heartflow, Inc. (NASDAQ: HTFL) in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 5,197,747 shares of the company's stock, valued at approximately $152,502,000. BlackRock Inc. owned 6.03% of Heartflow at the end of

Defense World • Aug 29, 2026
Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half

FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting Appropriate Use Criteria for cath lab referrals FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves…

GlobeNewsWire • Aug 28, 2026
Heartflow to Participate in the Wells Fargo 21st Annual Healthcare Conference

SAN FRANCISCO, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for diagnosing and managing coronary artery disease (CAD), today announced that members of management will participate in a fireside chat at the upcoming Wells Fargo 21st Annual Healthcare Conference. The fireside chat, which will include a slideshow presentation followed by a question-and-answer…

GlobeNewsWire • Aug 27, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for HTFL.

No House trades found for HTFL.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top